Archive: 10/04/2012

FDA to decide on Qnexa obesity drug in July

US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.

Waging war against rotavirus

Canada should show leadership in supporting adoption of the rotavirus vaccination in developing countries, but it must also ensure that all Canadian infants are vaccinated against the virus, states an editorial in CMAJ (Canadian ...

Words from a formerly fat physician

For obese patients, losing weight may require a different solution than calorie reduction and exercise, writes a formerly obese physician in CMAJ (Canadian Medical Association Journal).

page 4 from 7